SCHEMBL10024955

SCHEMBL10024955

Nc1ccc2cc(Cl)ncc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
CYP3A4 P08684 4/20 0.46
HSD17B10 Q99714 3/20 0.46
EGFR P00533 2/20 0.46
CASP1 P29466 2/20 0.45
HIF1A Q16665 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
ALOX15 P16050 1/20 0.45
CASP7 P55210 1/20 0.45
HBB P68871 1/20 0.45
MAPT P10636 5/20 0.43
KDM4E B2RXH2 5/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
PLAU P00749 1/20 0.41
HTT P42858 3/20 0.40
LMNA P02545 2/20 0.40
F2 P00734 1/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19681405 0.92 EGFR (0.46) ALDH1A1CYP3A4HSD17B10EGFRCASP1
SCHEMBL30676613 0.92 EGFR (0.46) ALDH1A1CYP3A4HSD17B10EGFRCASP1
SCHEMBL10976089 0.78 CYP2A6 (0.50) TP53CDC7CDK2GRM4
SCHEMBL31259166 0.78 PDPK1 (0.61) ALDH1A1CYP3A4HSD17B10EGFRCASP1
SCHEMBL9939593 0.76 PDPK1 (0.52) EGFRPDPK1CDC7CDK2PIK3CD
SCHEMBL24207389 0.75 CYP2A6 (0.57) ALDH1A1CYP3A4HSD17B10EGFRCASP1
SCHEMBL17374951 0.75 ALDH1A1 (0.54) ALDH1A1CYP3A4HSD17B10EGFRCASP1
SCHEMBL933672 0.75 CYP2A6 (0.46) ALDH1A1CYP3A4EGFRMAPTKDM4E
SCHEMBL10978740 0.75 L3MBTL1 (0.50) ALDH1A1TDP1MAPTKDM4E
SCHEMBL17336629 0.75 NOS1 (0.38) CYP3A4MAPTSLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116354879-A Benzamide derivative and application thereof 中国药科大学 2023-06-30 CN disclosed
WO-2012020036-A1 HEPATITIS C VIRUS INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-02-16 WO disclosed
US-20120039847-A1 Hepatitis C Virus Inhibitors ZHAO SHU-HAI (CN) 2012-02-16 US disclosed
US-20120039847-A1 Hepatitis C Virus Inhibitors ZHAO SHU-HAI (CN) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120039847-A1 Hepatitis C Virus Inhibitors HAVCR2, HCCS, LIPC ALDH1A1 802/4885CYP3A4 516/4885HSD17B10 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.